Detection of various autoantibodies in patients with pulmonary sarcoidosis Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019
Autoantibodies to the surfactant protein D in patients with interstitial lung diseases associated with amyopathic dermatomyositis and systemic sclerosis Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008
Utility of myositis related antibodies in interstitial lung disease and suspected autoimmunity. Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019
Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019 Year: 2020
Autoimmune pulmonary alveolar proteinosis complicated with sarcoidosis: clinical courses and serum levels of anti-GM-CSF autoantibody Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018
Pulmonary manifestations of myeloperoxidase-antineutrophil cytoplasmic antibody(MPO-ANCA)-related systemic vasculitis:CT findings in 50 patients Source: Eur Respir J 2002; 20: Suppl. 38, 267s Year: 2002
Evaluation of specific immune complexes in patients with pulmonary sarcoidosis. Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018
Pulmonary involvement in antisynthetase syndrome: more than myopathy Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases Year: 2021
Clinical features of interstitial lung disease in polymyositis and dermatomyositis Source: Eur Respir J 2006; 28: Suppl. 50, 828s Year: 2006
Auto-antibody subsets and extent of pulmonary fibrosis in systemic sclerosis (SSc) Source: Eur Respir J 2005; 26: Suppl. 49, 202s Year: 2005
Pulmonary involvement in systemic sclerosis Source: Eur Respir Monogr 2019; 86: 90-105 Year: 2019
Relationship between MIF and cellular pattern in BAL of patients with sarcoidosis, systemic sclerosis, idiopathic pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003
Pulmonary disorders in patients with polymyositis and dermatomyositis Source: Eur Respir J 2001; 18: Suppl. 33, 511s Year: 2001
Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005
Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013
Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis Source: Eur Respir J 2003; 22: 245-250 Year: 2003
Clinical significance of morphological indexes of inflammation and sclerosis in idiopathic fibrosing alveolitis (IFA) and lung sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 107s Year: 2002
Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody Source: Eur Respir Rev 2015; 24: 370-372 Year: 2015
Antinucleosome autoantibody in a patient with sarcoidosis and antiphospholipid antibodies Source: Annual Congress 2010 - Management of sarcoidosis and lung manifestations of systemic diseases Year: 2010
Non-organ-specific manifestations of sarcoidosis Source: Eur Respir Monogr 2022; 96: 206-222 Year: 2022